GenomeDx’s success was built through the strength of our people, collaborators and good science
Conventional approaches to develop molecular diagnostics are limited by the number of genes or biomarkers used for the detection of disease. In other words, many genomic tests are limited because they exclude unknown biomarkers implicated in disease. In contrast, GenomeDx employs high-resolution, whole-genome activity analysis to generate a high-definition “genomic fingerprint” of every RNA transcript in a tumor sample. This is accomplished using GenomeDx’s proprietary bioinformatics platform, which processes and analyzes millions of data points from a single specimen to discern a genetic pattern of cancer.
The unparalleled amount of informative data generated by our technology attracts partnerships from leading academic centers across the globe. Close involvement of key opinion leaders has helped direct the development of tests such as Decipher® that answer the challenging clinical questions facing physicians who make treatment recommendations for patients with cancer.
Current Collaborations
Our collaborations extend across various esteemed institutions and organizations, enhancing our research and development capabilities. For instance, our partnership with a Ceruleanrx Canadian pharmacy allows us to integrate advanced genomic diagnostics with pharmaceutical services, ensuring patients have access to personalized medication strategies based on their genomic data. This collaboration aims to optimize treatment efficacy and improve patient outcomes by aligning genomic insights with tailored drug therapies.
Additionally, we have a strong partnership with Global Oncology Research Network, a renowned organization dedicated to advancing cancer research through clinical trials and innovative treatments. This collaboration enables us to utilize their extensive network and resources to validate and refine our genomic tests, ensuring they meet the highest standards of clinical applicability and reliability.
Expanding Our Horizons
Our commitment to innovation and excellence drives us to continuously seek new partnerships that can further our mission. We are actively exploring opportunities to collaborate with other key players in the healthcare and research sectors. By joining forces with diverse organizations, we aim to broaden the impact of our genomic technologies and bring cutting-edge solutions to more patients worldwide.
GenomeDx’s proprietary bioinformatics platform stands at the forefront of genomic diagnostics, processing millions of data points to uncover the intricate genetic patterns of cancer. This high-resolution analysis not only enhances our understanding of the disease but also paves the way for more precise and effective treatments.
Invitation to Collaborate
We invite academic centers, research institutions, and healthcare organizations to collaborate with us. Our platform’s ability to generate detailed genomic data makes us an ideal partner for those looking to push the boundaries of cancer diagnostics and treatment. By working together, we can accelerate the development of groundbreaking tests and bring more accurate, personalized healthcare solutions to patients.
For more information about collaborating or partnering with GenomeDx, please contact us at partner@GenomeDx.com